Michael J. Zelefsky is joining NYU Langone’s Perlmutter Cancer Center as director of brachytherapy and vice chair for academic and faculty affairs in NYU Grossman School of Medicine’s Department of Radiation Oncology.
Hematologist-oncologist Navid Hafez was named director of precision medicine and thoracic oncology at the Angeles Clinic and Research Institute, an affiliate of Cedars-Sinai Cancer.
Mehran Habibi was named director of breast surgery for Staten Island University Hospital and chief of breast surgery for Northwell Health system’s Western Region, which includes Staten Island, Manhattan, and Westchester County. He will also serve as director of international program development for the Northwell Cancer Institute.
Avi Srivastava was named assistant professor in the Gene Expression and Regulation Program at the Ellen and Ronald Caplan Cancer Center at The Wistar Institute.
Sara Small was named assistant professor in the Department of Bone Marrow Transplant and Cellular Therapies at Fox Chase Cancer Center.
Amelie Ramirez, chair of the Department of Population Health Sciences and leader of Salud America! at UT Health San Antonio, won the 2023 Association of American Cancer Institutes Cancer Health Equity Award.
Jonathan D. LichtKeith McCraeJonathan Licht and Keith McCrae were selected by The American Society of Hematology to serve as the inaugural editors-in-chief of the newest additions to the Blood Journals portfolio: Blood Neoplasia and Blood Vessels, Thrombosis & Hemostasis, or Blood VTH.
Eric Kmiec, executive director and chief scientific officer of ChristianaCare’s Gene Editing Institute, has been selected as editor-in-chief of the scientific journal Gene and Genome Editing. Kmiec previously served three years on the journal’s board.
A multidisciplinary team at MUSC Hollings Cancer Center, led by Evan Graboyes, was awarded a $3.5 million grant to test an approach for reducing delays in care for head and neck cancer patients.
A multidisciplinary team of investigators from the UCLA Jonsson Comprehensive Cancer Center was awarded a $2.5 million Translational Team Science Award from the Department of Defense to develop a tailored treatment for glioblastoma, a deadly brain tumor with limited treatment options.
